Other · 2026
Review of how ibogaine might repair nerve insulation and brain energy use
- Original title
- Neurorestorative properties of ibogaine: linking multi-receptor affinities to remyelination and metabolic restoration.
- Authors
- Calvey T, Govender D, Owen GR, et al.
- Journal
- Acta neuropsychiatrica, 2026
- Molecules
- Ibogaine
- Conditions
- Substance use disorder, Other
- Evidence grade
- Very low
- Source
- Read the original paper
The question
Could ibogaine’s effects on many different brain receptors explain reports of lasting improvement in conditions such as addiction, multiple sclerosis and traumatic brain injury?
What they did
Researchers reviewed and discussed existing literature on ibogaine, a psychedelic plant alkaloid with no approved medical use. They focused on two possible mechanisms: remyelination (rebuilding the fatty insulation, called myelin, around nerve fibres) and restoration of normal energy metabolism in the brain. They also drew on observational clinical reports linking a single dose of ibogaine to symptom relief in several neuropsychiatric conditions.
What they found
The authors report evidence that ibogaine raises markers of myelination after opioid exposure, and that opioid use disorder, multiple sclerosis and traumatic brain injury all involve damage to the brain’s white matter (the myelin-rich wiring). They argue that reduced myelination is tied to disrupted metabolism, poor blood supply and low oxygen. They propose that ibogaine’s binding to NMDA, kappa opioid and sigma receptors could reduce nerve overexcitation, support metabolism, promote lasting brain plasticity and calm immune activity. No new patient data or outcome numbers are presented in the abstract.
The fine print
This is a narrative review, not a clinical trial, so it cannot show that ibogaine helps anyone. The human evidence it cites is observational, which cannot establish cause and effect, and much of the mechanistic evidence appears to come from laboratory work. Ibogaine has known serious cardiac risks that this abstract does not address, and this summary is based on the abstract alone.
What it means
The paper offers a biological rationale for why ibogaine might aid nerve repair, but it is a hypothesis for future research rather than evidence that ibogaine treats these conditions.
Evidence grade: Very low. This is a narrative review of mechanisms rather than a new study in people, and it reports no trial data or participant numbers.
This summary is based on the study’s published abstract.